BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 23635947)

  • 1. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
    Kaniwa N; Saito Y
    J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics and the potential for predictive tests in adverse drug reactions.
    Pirmohamed M
    Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte antigens and drug hypersensitivity.
    Chung WH; Hung SI; Chen YT
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotyping for severe drug hypersensitivity.
    Karlin E; Phillips E
    Curr Allergy Asthma Rep; 2014 Mar; 14(3):418. PubMed ID: 24429903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA alleles and drug hypersensitivity reactions.
    Profaizer T; Eckels D
    Int J Immunogenet; 2012 Apr; 39(2):99-105. PubMed ID: 22136512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention.
    Gerogianni K; Tsezou A; Dimas K
    Mol Diagn Ther; 2018 Jun; 22(3):297-314. PubMed ID: 29564734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of hypersensitivity drug reactions.
    Negrini S; Becquemont L
    Therapie; 2017 Apr; 72(2):231-243. PubMed ID: 28162244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetic markers of severe cutaneous adverse drug reactions.
    Borroni RG
    G Ital Dermatol Venereol; 2014 Apr; 149(2):219-26. PubMed ID: 24819643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-associated antiepileptic drug-induced cutaneous adverse reactions.
    Mullan KA; Anderson A; Illing PT; Kwan P; Purcell AW; Mifsud NA
    HLA; 2019 Jun; 93(6):417-435. PubMed ID: 30895730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The associations between idiosyncratic adverse drug reactions and HLA alleles and their underlying mechanism].
    Wang Q; Mei H; Zhang YL; Pan XC; Tan W; Chao L
    Yao Xue Xue Bao; 2013 Jun; 48(6):799-808. PubMed ID: 23984511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on HLA alleles associated with adverse drug reactions.
    Fricke-Galindo I; LLerena A; López-López M
    Drug Metab Pers Ther; 2017 May; 32(2):73-87. PubMed ID: 28315856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.
    White KD; Chung WH; Hung SI; Mallal S; Phillips EJ
    J Allergy Clin Immunol; 2015 Aug; 136(2):219-34; quiz 235. PubMed ID: 26254049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity.
    Michels AW; Ostrov DA
    J Allergy Clin Immunol; 2015 Aug; 136(2):252-7. PubMed ID: 26254052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation.
    Su SC; Hung SI; Fan WL; Dao RL; Chung WH
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review.
    Yip VL; Alfirevic A; Pirmohamed M
    Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):165-75. PubMed ID: 24777842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review.
    Cheng CY; Su SC; Chen CH; Chen WL; Deng ST; Chung WH
    J Immunol Res; 2014; 2014():565320. PubMed ID: 24901010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics of drug hypersensitivity.
    Phillips EJ; Mallal SA
    Pharmacogenomics; 2010 Jul; 11(7):973-87. PubMed ID: 20602616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
    Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
    J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA and pharmacogenetics of drug hypersensitivity.
    Pavlos R; Mallal S; Phillips E
    Pharmacogenomics; 2012 Aug; 13(11):1285-306. PubMed ID: 22920398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA Association with Drug-Induced Adverse Reactions.
    Fan WL; Shiao MS; Hui RC; Su SC; Wang CW; Chang YC; Chung WH
    J Immunol Res; 2017; 2017():3186328. PubMed ID: 29333460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.